Related Experiment Video
Updated: Jun 10, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.2K
Mechanical circulatory support in cardiogenic shock patients
Luis Martin-Villen1, Alejandro Adsuar-Gomez2, Jose Manuel Garrido-Jimenez3
1Department of Intensive Care Medicine, Hospital Universitario Virgen del Rocío, Seville, Spain.
Medicina Intensiva
|October 11, 2024
Summary
Cardiogenic shock (CS) management involves addressing the cause and providing circulatory support. Mechanical circulatory support (MCS) is crucial for refractory CS, requiring careful device selection and comprehensive patient care.
Area of Science:
- Cardiology
- Critical Care Medicine
Background:
- Cardiogenic shock (CS) is a severe condition requiring prompt intervention.
- Refractory CS often necessitates mechanical circulatory support (MCS) to maintain circulation.
- Multiorgan failure is a significant risk in advanced CS.
Purpose of the Study:
- To outline the management strategy for cardiogenic shock.
- To detail the role and considerations for mechanical circulatory support in CS.
- To emphasize comprehensive care and protocolized withdrawal of MCS.
Main Methods:
- Review of current clinical practices for CS management.
- Analysis of indications and device selection for MCS.
- Discussion of complications and care protocols for MCS patients.
Main Results:
- Early resolution of CS cause and circulatory support are key.
- MCS selection depends on CS etiology, duration, and patient comorbidities.
- Comprehensive monitoring, management, and protocolized withdrawal of MCS are essential.
Conclusions:
- Effective CS management integrates addressing the cause with circulatory support.
- MCS is a vital tool in refractory CS, demanding tailored device choice and vigilant care.
- Structured protocols for MCS management and withdrawal improve patient outcomes.
Related Concept Videos
01:24Blood Pressure Imbalances and Circulatory Shock
758
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
758
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
2
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
2
01:30Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
01:22Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
01:21Cardiopulmonary Resuscitation I: Adult
4
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
4
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
3
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
3